av/newron-pharma-n--big.svg

COM:NEWRON

Newron Pharmaceuticals

  • Stock

CHF

Last Close

7.20

25/11 08:59

Market Cap

136.34M

Beta: -

Volume Today

6.96K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
267K
-
201.50K
24.53%
70K
65.26%
21.50K
69.29%
5K
76.74%
2.50K
50%
0.50
-
average payables
1.60M
-
1.18M
26.12%
1.34M
13.55%
1.81M
34.94%
2.10M
16.22%
1.69M
19.83%
1.78M
5.43%
1.84M
3.49%
1.39M
24.54%
1.71M
22.91%
1.96M
15.12%
average receivables
4.55M
-
2.73M
40.02%
972K
-
book value per share
1.83
-
2.31
25.86%
2.70
17.26%
3.39
25.23%
4.15
22.67%
3.07
26.02%
2.06
32.91%
0.97
53.13%
0.17
81.98%
-0.79
551.56%
-1.68
113.17%
capex per share
-0.01
-
-0.00
73.74%
-0.00
168.95%
-0.00
5.10%
-0.00
22.40%
-0.00
41.07%
-0.00
27.49%
-0.00
31.37%
-0.00
42.86%
-0.00
10.00%
-0.00
38.89%
capex to depreciation
-1.95
-
-0.67
65.79%
-0.90
35.21%
-2.18
142.05%
-1.29
40.80%
-0.85
34.11%
-0.25
70.91%
-0.16
35.45%
-0.10
40.12%
-0.09
6.88%
-0.05
38.58%
capex to operating cash flow
0.01
-
0.00
69.06%
0.00
126.13%
0.00
26.11%
0.01
100.66%
0.00
66.34%
0.00
7.53%
0.00
2.22%
0.00
22.17%
0.00
7.14%
0.00
33.15%
capex to revenue
-0.02
-
-0.01
34.20%
-0.03
90.31%
-0.01
60.19%
-0.00
56.87%
-0.01
115.24%
-0.01
27.08%
-0.01
8.14%
-0.00
47.86%
-0.00
14.90%
-0.00
58.88%
cash per share
2.08
-
2.03
2.38%
2.98
47.23%
3.16
6.06%
3.69
16.51%
2.46
33.33%
2.19
10.70%
1.75
20.21%
1.94
10.70%
1.28
34.17%
0.71
44.68%
days of inventory on hand
408.42
-
78.05
80.89%
10.99
85.92%
0.69
93.70%
days payables outstanding
1.79K
-
800.40
55.18%
473.17
40.88%
274.79
41.93%
305.67
-
616.27
101.61%
1.58K
155.58%
days sales outstanding
562.82
-
debt to assets
0.05
-
0.03
35.85%
0.02
44.21%
0.01
60.68%
0.28
-
0.51
83.71%
0.85
65.83%
1.23
43.87%
1.87
52.47%
debt to equity
0.07
-
0.04
45.78%
0.02
47.34%
0.01
62.60%
0.46
-
1.53
232.88%
13.87
807.68%
-3.25
123.47%
-1.62
50.26%
dividend yield
earnings yield
-0.05
-
-0.04
18.98%
-0.07
94.06%
-0.06
22.19%
-0.03
40.73%
-0.16
382.78%
-0.19
22.76%
-0.59
204.93%
-0.53
9.70%
-0.62
17.01%
-0.17
72.67%
enterprise value
140.44M
-
258.66M
84.18%
286.54M
10.78%
233.63M
18.47%
105.28M
54.94%
67.64M
35.76%
99.13M
46.56%
48.67M
50.90%
45.99M
5.51%
60.26M
31.02%
137.18M
127.64%
enterprise value over ebitda
-18.15
-
-23.13
27.44%
-12.07
47.83%
-15.53
28.73%
-20.37
31.13%
-4.53
77.74%
-5.11
12.79%
-2.84
44.54%
-3.91
37.92%
-4.52
15.62%
-11.59
156.34%
ev to operating cash flow
-13.14
-
-25.87
96.85%
-22.28
13.89%
-11.93
46.45%
-12.53
5.00%
-4.20
66.48%
-4.46
6.30%
-3.12
30.04%
-4.02
28.70%
-5.43
35.19%
-13.53
149.01%
ev to sales
39.68
-
166.13
318.63%
120.39
27.53%
34.74
71.15%
7.84
77.43%
16.80
114.33%
14.08
16.18%
9.26
34.28%
7.98
13.77%
9.89
23.88%
15.15
53.16%
free cash flow per share
-0.94
-
-0.79
15.54%
-0.94
19.26%
-1.34
42.06%
-0.52
61.19%
-0.90
74.24%
-1.25
37.85%
-0.88
29.82%
-0.64
26.61%
-0.62
3.10%
-0.57
8.63%
free cash flow yield
-0.07
-
-0.04
46.96%
-0.04
10.77%
-0.07
77.17%
-0.05
26.36%
-0.17
223.50%
-0.21
25.91%
-0.44
105.94%
-0.41
6.62%
-0.40
3.41%
-0.11
73.08%
graham net net
1.53
-
1.41
7.52%
2.45
73.57%
2.70
9.91%
3.36
24.57%
2.18
35.02%
0.88
59.78%
-0.15
117.24%
-0.72
373.17%
-1.59
122.53%
-2.42
51.75%
graham number
5.04
-
6.43
27.43%
10.06
56.53%
8.89
11.61%
5.50
38.10%
7.63
38.69%
7.25
5.04%
5.06
30.21%
1.81
64.24%
4.16
130.24%
5.86
40.61%
income quality
1.39
-
0.93
32.70%
0.51
44.78%
1.29
150.18%
1.59
23.09%
1.07
32.35%
1.10
2.71%
0.79
27.87%
0.77
3.23%
0.63
17.44%
0.63
1.40%
intangibles to total assets
0.29
-
0.19
34.64%
0.01
96.83%
0.00
22.76%
0.00
89.61%
0.00
4.79%
0.00
33.95%
0.00
35.23%
0.00
81.56%
0
100%
0
interest coverage
123.43
-
22.79
81.53%
-20.91
191.72%
-116.10
455.27%
-51.13
55.96%
-267.46
423.11%
-36.54
86.34%
-8.07
77.92%
-4.23
47.52%
-3.37
20.42%
-2.79
17.21%
interest debt per share
0.12
-
0.05
60.94%
0.14
194.13%
0.03
75.52%
0.01
84.56%
0.00
39.82%
0.98
31,075.04%
1.60
63.72%
2.58
60.93%
2.78
7.85%
2.95
5.99%
inventory turnover
0.89
-
4.68
423.28%
33.21
610.16%
526.80
1,486.24%
invested capital
0.07
-
0.04
45.78%
0.02
47.34%
0.01
62.60%
0.46
-
1.53
232.88%
13.87
807.68%
-3.25
123.47%
-1.62
50.26%
market cap
157.42M
-
276.33M
75.54%
321.82M
16.46%
276.21M
14.17%
161.56M
41.51%
95.26M
41.04%
104.29M
9.48%
35.54M
65.92%
27.93M
21.41%
28.02M
0.33%
95.10M
239.36%
net current asset value
11.27M
-
21.57M
91.45%
36.71M
70.13%
49.30M
34.30%
67.50M
36.92%
54.63M
19.07%
36.46M
33.26%
3.92M
89.24%
-7.95M
302.75%
-22.73M
185.87%
-36.12M
58.90%
net debt to ebitda
2.19
-
1.58
28.01%
1.49
5.96%
2.83
90.55%
10.89
284.64%
1.85
83.00%
0.27
85.61%
-0.77
387.19%
-1.54
100.75%
-2.42
57.51%
-3.56
46.98%
net income per share
-0.62
-
-0.80
29.02%
-1.66
108.95%
-1.04
37.61%
-0.32
68.76%
-0.84
160.02%
-1.13
34.39%
-1.18
3.91%
-0.84
29.04%
-0.98
17.39%
-0.91
7.25%
operating cash flow per share
-0.93
-
-0.79
15.13%
-0.94
18.93%
-1.33
42.24%
-0.52
61.33%
-0.90
75.09%
-1.24
37.87%
-0.87
29.82%
-0.64
26.58%
-0.62
3.08%
-0.57
8.58%
payables turnover
0.20
-
0.46
123.10%
0.77
69.16%
1.33
72.19%
1.19
-
0.59
50.40%
0.23
60.87%
receivables turnover
0.65
-
research and ddevelopement to revenue
1.28
-
3.86
201.44%
7.75
100.59%
1.84
76.22%
0.64
65.27%
1.23
91.57%
1.71
39.15%
1.97
15.40%
1.86
5.48%
1.97
5.84%
1.45
26.29%
return on tangible assets
-0.32
-
-0.34
6.35%
-0.52
54.11%
-0.27
47.70%
-0.07
73.25%
-0.25
248.00%
-0.34
33.14%
-0.41
22.35%
-0.30
28.05%
-0.47
59.34%
-0.63
33.37%
revenue per share
0.31
-
0.12
60.09%
0.17
41.32%
0.46
164.02%
0.82
79.90%
0.23
72.62%
0.39
74.85%
0.29
25.29%
0.32
9.59%
0.34
5.76%
0.51
48.62%
roe
-0.34
-
-0.34
2.51%
-0.61
78.20%
-0.31
50.18%
-0.08
74.54%
-0.27
251.48%
-0.55
100.31%
-1.22
121.72%
-4.80
293.90%
1.25
126.00%
0.54
56.49%
roic
-0.32
-
-0.35
9.56%
-0.59
69.28%
-0.31
47.96%
-0.06
79.14%
-0.27
327.54%
-0.39
42.34%
-0.44
12.26%
-0.26
39.40%
-0.41
56.57%
-0.62
48.72%
sales general and administrative to revenue
1.07
-
2.32
116.62%
1.80
22.30%
0.68
62.17%
0.29
56.81%
1.28
334.48%
0.91
28.75%
0.94
2.76%
0.61
35.32%
0.58
4.28%
0.44
24.23%
shareholders equity per share
1.83
-
2.31
25.86%
2.70
17.26%
3.39
25.23%
4.15
22.67%
3.07
26.02%
2.06
32.91%
0.97
53.13%
0.17
81.98%
-0.79
551.56%
-1.68
113.17%
stock based compensation to revenue
0.24
-
0.79
235.62%
0.95
19.72%
0.34
64.08%
0.13
61.88%
0.52
304.21%
0.30
42.29%
0.28
8.02%
0.13
52.41%
0.08
40.44%
0.02
72.39%
tangible asset value
11.96M
-
22.27M
86.11%
36.85M
65.47%
49.49M
34.30%
67.69M
36.78%
54.81M
19.02%
36.78M
32.90%
17.23M
53.14%
3.10M
81.98%
-14.03M
551.85%
-29.91M
113.17%
tangible book value per share
1.04
-
1.76
68.83%
2.69
52.98%
3.37
25.47%
4.15
23.25%
3.07
26.02%
2.06
32.87%
0.97
53.13%
0.17
81.98%
-0.79
551.56%
-1.68
113.17%
working capital
15.73M
-
24.90M
58.32%
37.46M
50.45%
49.49M
32.12%
68.07M
37.54%
55.23M
18.87%
54.35M
1.59%
30.98M
43.00%
35.77M
15.46%
23.45M
34.44%
-9.27M
139.54%

All numbers in CHF (except ratios and percentages)